DBFM
GSK icon

Dickmeyer Boyce Financial Management’s GSK GSK Stock Holding History

Dickmeyer Boyce Financial Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3,870
Closed -$203K – 129
2026
Q2 		$203K Sell
3,870
-50
-1% -$2.64K 0.11% 127
2026
Q1 		$216K Buy
+3,920
New +$212K 0.13% 113

Other funds holding GSK

KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
BE
Bonness Enterprises Washington, District of Columbia $307M AUM 22.88% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return

Dickmeyer Boyce Financial Management's GSK Position: Q3 2026 in Review

Dickmeyer Boyce Financial Management sold out of GSK (GSK) in Q3 2026, closing a stake of 3,870 shares — an estimated $203K sold.

Dickmeyer Boyce Financial Management first reported a position in GSK in Q1 2026 and held it in 2 quarters. The position peaked at $216K in Q1 2026. 31 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Dickmeyer Boyce Financial Management reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
  • Dickmeyer Boyce Financial Management sold 3,870 GSK shares in Q3 2026, an estimated $203K.
  • Dickmeyer Boyce Financial Management first reported a position in GSK in Q1 2026 and held it in 2 quarters.
  • Dickmeyer Boyce Financial Management's GSK position peaked at $216K in Q1 2026.
  • 31 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Dickmeyer Boyce Financial Management's 13F filing for Q3 2026, filed 8 Oct 2026.